Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland

被引：0

作者：

Radecka, B. ^{[1
]}

Gelej, M. ^{[2
]}

Streb, J. ^{[3
]}

Siedlaczek, A. ^{[4
]}

Kryka, K. ^{[3
]}

Tokajuk, P. ^{[5
]}

Winsko-Szczesnowicz, K. ^{[5
]}

Czernek, U. ^{[6
]}

Sobczak, M. ^{[7
]}

Malik, M. ^{[8
]}

Bodnar, L. ^{[9
]}

Foszczynska-Kloda, M. ^{[10
]}

Hetman, K. ^{[10
]}

Skiewicz, M. Welnicka-Ja ^{[11
]}

Wierzbicka, K. ^{[11
]}

Orlikowska, M. ^{[12
]}

Becht, R. ^{[13
]}

Deptala, A. ^{[14
]}

Itrych, B. ^{[15
]}

Kania-Zembaczynska, B. ^{[16
]}

机构：

[1] Univ Opole, Inst Med Sci, Dept Oncol, Opole, Poland

[2] Tadeusz Koszarowski Reg Canc Ctr, Dept Clin Oncol, Opole, Poland

[3] Jagiellonian Univ Hosp Krakow, Krakow, Poland

[4] Univ Opole, Inst Math & Comp Sci, Opole, Poland

[5] Comprehens Canc Ctr Bialystok, Med Oncol Dept, Bialystok, Poland

[6] Med Univ Lodz, Copernicus Mem Hosp Lodz, Dept Chemotherapy, Lodz, Poland

[7] Copernicus Mem Hosp Lodz, Lodz, Poland

[8] Lower Silesian Oncol Ctr, Clin Oncol Dept, Wroclaw, Poland

[9] Warmia & Mazury Oncol Ctr, MSWiA Hosp, Oncol & Immunooncol Clin, Olsztyn, Poland

[10] West Pomeranian Oncol Ctr Szczecin, Szczecin, Poland

[11] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

[12] Kociewie Hlth Ctr Starogard Gdanski, Oncol Dept, Starogard Gdanski, Poland

[13] Pomeranian Med Univ, Clin Dept Oncol Chemotherapy & Canc Immunotherapy, Szczecin, Poland

[14] Med Univ Warsaw, Cent Clin Hosp MSWiA, Clin Oncol & Hematol, Warsaw, Poland

[15] Cent Clin Hosp MSWiA, Clin Oncol & Breast Dis, Ctr Postgrad Med Educ, Warsaw, Poland

[16] Beskidian Oncol Ctr Bielsko Biala, Dept Oncol & Oncohematol, Bielsko Biala, Poland

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.04.139

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-57

引用

页码：S108 / S108

页数：1

共 50 条

[31] Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
Malik, Mateusz
Michalak, Maciej
Radecka, Barbara
Gelej, Marek
Jackowska, Aleksandra
Filipczyk-Cisarz, Emilia
Hetman, Katarzyna
Foszczynska-Kloda, Malgorzata
Kania-Zembaczynska, Beata
Manka, Danuta
Orlikowska, Marlena
Rogowska-Dros, Hanna
Bodnar, Lubomir
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
[32] Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
Agnieszka Koper
Sławomir Wileński
Paulina Śledzińska
Marek Bebyn
Krzysztof Koper
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10867 - 10877
[33] Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Prager, Gerald W.
Taieb, Julien
Fakih, Marwan
Ciardiello, Fortunato
Van Cutsem, Eric
Elez, Elena
Cruz, Felipe M.
Wyrwicz, Lucjan
Stroyakovskiy, Daniil
Papai, Zsuzsanna
Poureau, Pierre-Guillaume
Liposits, Gabor
Cremolini, Chiara
Bondarenko, Igor
Modest, Dominik P.
Benhadji, Karim A.
Amellal, Nadia
Leger, Catherine
Vidot, Loick
Tabernero, Josep
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1657 - 1667
[34] The REWRITE Study-REal-WoRld effectIveness of TrifluridinE/tipiracil in Patients with Previously Treated Metastatic Colorectal Cancer
Marques, D.
Costa, A. L.
Mansinho, A.
Quintela, A.
Pratas, E.
Brito-da-Silva, J.
Cruz, J.
Felix, J.
Rodrigues, J.
Mota, M.
Teixeira, A. R.
Damaso, S.
Pinheiro, S.
Andreozzi, V.
Costa, L.
Barros, A. G.
CLINICAL ONCOLOGY, 2023, 35 (10) : 665 - 672
[35] Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
Niisato, Yusuke
Moriwaki, Toshikazu
Fukuoka, Shota
Masuishi, Toshiki
Takashima, Atsuo
Kumekawa, Yosuke
Kajiwara, Takeshi
Yamazaki, Kentaro
Esaki, Taito
Makiyama, Akitaka
Denda, Tadamichi
Hatachi, Yukimasa
Suto, Takeshi
Sugimoto, Naotoshi
Shimada, Yasuhiro
ANTICANCER RESEARCH, 2021, 41 (04) : 2203 - 2207
[36] Trifluridine/tipiracil in metastatic colorectal cancer: a guide to its use
Lyseng-Williamson K.A.
Burness C.B.
Duggan S.T.
Drugs & Therapy Perspectives, 2017, 33 (3) : 110 - 118
[37] Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
A. Fernandez Montes
F. Vazquez Rivera
N. Martinez Lago
M. Covela Rúa
A. Cousillas Castiñeiras
P. Gonzalez Villarroel
J. de la Cámara Gómez
J. C. Méndez Méndez
M. Salgado Fernández
S. Candamio Folgar
M. Reboredo López
M. Carmona Campos
E. Gallardo Martín
M. Jorge Fernández
M. L. Pellón Augusto
L. París Bouzas
J. García Gómez
Clinical and Translational Oncology, 2020, 22 : 351 - 359
[38] Safety of trifluridine/tipiracil for metastatic colorectal cancer in African American patients participating in an expanded access program.
Philip, Philip Agop
Smaglo, Brandon George
El-Rayes, Bassel F.
Lesuisse, Christian
Makris, Lukas
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[39] Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
Fernandez Montes, A.
Vazquez Rivera, F.
Martinez Lago, N.
Covela Rua, M.
Cousillas Castineiras, A.
Gonzalez Villarroel, P.
De la Camara Gomez, J.
Mendez Mendez, J. C.
Salgado Fernandez, M.
Candamio Folgar, S.
Reboredo Lopez, M.
Carmona Campos, M.
Gallardo Martin, E.
Jorge Fernandez, M.
Pellon Augusto, M. L.
Paris Bouzas, L.
Garcia Gomez, J.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (03): : 351 - 359
[40] Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study
Garcia-Alfonso, Pilar
Munoz, Andres
Jimenez-Castro, Jeronimo
Jimenez-Fonseca, Paula
Pericay, Carles
Longo-Munoz, Federico
Reyna-Fortes, Carmen
Argiles-Martinez, Guillem
Gonzalez-Astorga, Beatriz
Jose Gomez-Reina, Maria
Ruiz-Casado, Ana
Rodriguez-Salas, Nuria
Lopez-Lopez, Rafael
Carmona-Bayonas, Alberto
Conde-Herrero, Veronica
Aranda, Enrique
CANCERS, 2021, 13 (18)

← 1 2 3 4 5 →